Company Overview and News

 
Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update

2018-08-30 globenewswire
VICTORIA, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald” or “the Company”) has filed its financial statements and management discussion and analysis for the three and six months ended June 30, 2018. They are available for viewing on www.sedar.com or on the Company’s website. All figures are expressed in Canadian dollars unless otherwise stated.
ATTBF EMH TBQBF EMHTF ATT QBC

 
Nemaska Lithium, Inc., CEO Guy Bourassa Visits Uptick Newswire’s ‘Stock Day’ Podcast With Everett Jolly

2018-08-29 globenewswire
PHOENIX, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Nemaska Lithium, Inc., (OTCQB:NMKEF) (the “Company”) CEO Guy Bourassa is making another stop on Uptick Newswire’s “Stock Day” podcast with Everett Jolly.
NMX TXTW QBC NMKEF

 
Liberal reforms took 'courage,' Couillard says as Quebec election gets underway

2018-08-23 cbc.ca
As he began his quest for a second term, Quebec Liberal Leader Philippe Couillard portrayed his party as a trusted economic steward that made difficult, but necessary decisions to get the province back on track.
QBC

 
Heckle heard around the country offers sneak peek at 2019 campaign narrative

2018-08-22 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
QBC

 
HPQ Closes $ 5,250,000 Financing

2018-08-21 globenewswire
MONTREAL, Aug. 21, 2018 (GLOBE NEWSWIRE) -- HPQ Silicon Resources Inc (“HPQ”) (TSX Venture: HPQ) is pleased to announce the closing of the previously announced financings totalling $ 5,250,000 with participation of the Quebec government, via its “Créativité Québec” program, and PyroGenesis Canada Inc. (“PyroGenesis”).
PYRNF PYR QBC

 
How hydrogen could shake up Canada's energy sector

2018-08-19 cbc.ca
A few decades ago there was hype around hydrogen because of how one day it may replace gasoline and diesel as the fuel most use to fill up their tanks. The use of hydrogen is still in its infancy, but it's growing in Canada. The potential is significant for how the most abundant element in the universe could change the country's transportation, electricity and energy sectors.
QBC

 
Canadian astronaut David Saint-Jacques begins final training for ISS mission

2018-08-17 cbc.ca
For Canadian astronaut David Saint-Jacques, it's all about preparation as he continues his training four months before he blasts off into space.
QBC

 
Metro Inc. (MTRAF) CEO Eric La Flèche on Q3 2018 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Good morning. My name is Simon, and I will be your conference operator today. At this time, I would like to welcome everyone to the Metro Inc., 2018 Third Quarter Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. [Operator Instructions] Thank you.
MTRAF MTTRY QBC

 
HPQ Secures $ 5,250,000 in Financing; the PUREVAP™ Process is the Green Solution for the Solar Industry

2018-08-13 globenewswire
MONTREAL, Aug. 13, 2018 (GLOBE NEWSWIRE) -- HPQ Silicon Resources Inc (“HPQ”) (TSX VENTURE:HPQ) (FRANKFURT:UGE) (OTC PINK:URAGF) is pleased to announce the participation of the Quebec government, via its “Créativité Québec” program, and PyroGenesis Canada Inc. (“PyroGenesis”) in financings totalling $ 5,250,000. These financing, subject to certain conditions, will be earmarked toward the completion of the “Gen 3 PUREVAP™” pilot equipment project announced in August 2016.
PYRNF PYR QBC

1
Quebec weighs legal options as judge temporarily suspends face-covering law

2018-06-29 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
QBC

6
Canada Strategic Metals and Matamec Close $5.4 Million and Create Quebec Precious Metals Corporation

2018-06-29 globenewswire
MONTREAL, June 28, 2018 (GLOBE NEWSWIRE) -- Canada Strategic Metals Inc. (“Canada Strategic” or the Company) (TSX.V:CJC), Matamec Explorations Inc. (“Matamec”) (TSX.V:MAT) and Sphinx Resources Ltd. (“Sphinx”) (TSX.V:SFX) are pleased to announce that Canada Strategic and Matamec have closed the business combination by way of the plan of arrangement approved by an order of Superior Court of Canada (the “Arrangement”), announced on April 26, 2018, to create a new gold exploration company whose activities will be focused on the James Bay region.
SOI CJCFF SIREF TYHOF SMD SFX DRGDF QBC MAT MHREF DONFF DGC CJC 8015 GG SMDZF

1
Confusion reigns over guidelines for Quebec's face-covering ban

2018-06-28 cbc.ca
With Quebec's new guidelines on religious accommodation set to go into effect in a matter of days, public workers are still seeking clarity on how to implement the law.
QBC

1
Flood damage inspector used government position to try to get his 'guy' renovation contracts

2018-06-19 cbc.ca
A man whose house was heavily damaged during the 2017 spring floods says his government-authorized evaluator used his position to try to get an acquaintance and business partner the contract to repair his Île-Bizard home.
QBC

1
Airbus set to close deal for majority stake in Bombardier Cseries

2018-06-08 channelnewsasia
Airbus SE is set to close a deal to take a controlling stake in Bombardier Inc's CSeries jetliner program, effective July 1, the companies said on Friday, in a move expected to kickstart the European planemaker's ability to put its marketing and cost-cutting muscle into the Canadian plane program.
BDRPF QBC

1
Airbus set to close deal for majority stake in Bombardier Cseries

2018-06-08 reuters
(Reuters) - Airbus SE (AIR.PA) is set to close a deal to take a controlling stake in Bombardier Inc’s (BBDb.TO) CSeries jetliner program, effective July 1, the companies said on Friday, in a move expected to kickstart the European planemaker’s ability to put its marketing and cost-cutting muscle into the Canadian plane program.
BDRPF QBC

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:QBC / QUEBEC on message board site Silicon Investor.

Buying QBC Buying QBC Buying QBC